The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Popova E.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Barabanova M.A.

Antipova L.N.

Bakhtiiarova K.Z.

Bashkirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Ufa

Belova A.N.

Yaroslavl Regional Clinical Oncological Hospital, Yaroslavl, Russia

Solov'eva V.S.

GBUZ «Gorodskaja klinicheskaja bolnitsa №3», Nizhniĭ Novgorod

Bel'skaia G.N.

Kafedra nevrologii fakul'teta poslevuzovskogo i dopolnitel'nogo professional'nogo obrazovaniia GBOU VPO "Iuzhno-Ural'skiĭ gosudarstvennykh meditsinskiĭ universitet" Minzdrava Rossii, Cheliabinsk

Lukashevich I.G.

Nevrologicheskaia sluzhba polikliniki MBUZ GKB #1, Cheliabinsk

Nikolaeva L.I.

City Center of Multiple Sclerosis of City Clinical Hospital №1, Chelyabinsk, Russia

Volkova L.I.

Ural State Medical Academy, Ekaterinburg

Turova E.L.

GBUZ «Sverdlovskaja oblastnaja klinicheskaja bolnitsa №1», Ekaterinburg

Kraeva A.V.

Sverdlovsk Regional Clinical Hospital №1, Yekaterinburg, Russia;
City Center of Multiple Sclerosis, Rostov-on-Don, Russia

Goncharova Z.A.

Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Rostov-na-Donu

Malkova N.A.

Novosibirskiĭ okruzhnoĭ tsentr rasseiannogo skleroza

Poverennova I.E.

Kafedra nevrologii i neĭrokhirurgii Samarskogo gosudarstvennogo meditsinskogo universiteta

Sivertseva S.A.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza

Zhelnin A.V.

GBOU VPO «Permskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. E.A. Vagnera» Minzdrava RF;
GBUZ PK «Permskaja kraevaja klinicheskaja bolnitsa», Perm

Trushnikova T.N.

GBOU VPO "Permskaia gosudarstvennaia meditsinskaia akademiia im. akad. E.A. Vagnera", Perm'

Khabirov F.A.

Kazanskaia gosudarstvennaia meditsinskaia akademiia Minzdravsotsrazvitiia Rossii;
Respublikanskiĭ kliniko-diagnosticheskiĭ tsentr po demieliniziruiushchim zabolevaniiam Ministerstva zdravookhraneniia Respubliki Tatarstan, Kazan'

Khaĭbullin T.I.

Kazanskaia gosudarstvennaia meditsinskaia akademiia Minzdravsotsrazvitiia Rossii;
Respublikanskiĭ kliniko-diagnosticheskiĭ tsentr po demieliniziruiushchim zabolevaniiam Ministerstva zdravookhraneniia Respubliki Tatarstan, Kazan'

Primary progressive multiple sclerosis: current issues of timely diagnosis

Authors:

Popova E.V., Boĭko A.N., Barabanova M.A., Antipova L.N., Bakhtiiarova K.Z., Belova A.N., Solov'eva V.S., Bel'skaia G.N., Lukashevich I.G., Nikolaeva L.I., Volkova L.I., Turova E.L., Kraeva A.V., Goncharova Z.A., Malkova N.A., Poverennova I.E., Sivertseva S.A., Zhelnin A.V., Trushnikova T.N., Khabirov F.A., Khaĭbullin T.I.

More about the authors

Read: 2623 times


To cite this article:

Popova EV, Boĭko AN, Barabanova MA, et al. . Primary progressive multiple sclerosis: current issues of timely diagnosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(10‑2):35‑40. (In Russ.)
https://doi.org/10.17116/jnevro201711710235-40

References:

  1. Bosch X. Multiple Sclerosis History. JAMA. 2005;294(3):374. https://doi.org/10.1001/jama.294.3.376-b
  2. Kurtzke J. MS epidemiology world wide. One view of current status. Acta Neurologica Scandinavica. 1995;91(161):23-33. https://doi.org/10.1111/j.1600-0404.1995.tb05853.x
  3. Gusev EI, Boiko AN. Multiple sclerosis: the progress over the past decade. Neuroscience and behavioral physiology (special edition «Multiple sclerosis»). 2007;107:4:4-14. (In Russ.)
  4. Gusev EI, Boyko AN. Multiple sclerosis: knowledge for therapy. Medical Journal of the Russian Federation. 2001;1:4-10. (In Russ.)
  5. Multiple sclerosis. Clinical guideline. Edited by Gusev E.I., Zavalishin I.A., Boyko A.N. M.: Real Time; 2011. (In Russ.)
  6. Montalban X. Primary progressive multiple sclerosis. Current Opinion in Neurology. 2005;18(3):261-266. https://doi.org/10.1097/01.wco.0000169742.37159.e9
  7. Ebers G. Natural history of primary progressive multiple sclerosis. Multiple Sclerosis. 2004;10(1 suppl):8-15. https://doi.org/10.1177/135245850401000103
  8. Tremlett H, Paty D, Devonshire V. The natural history of primary progressive MS in British Columbia, Canada. Neurology. 2005;65(12):1919-1923. https://doi.org/10.1212/01.wnl.0000188880.17038.1
  9. Confavreux C, Vukusic S. Reply to: Age at disability milestones in multiple sclerosis and history of multiple sclerosis: a unifying concept. Brain. 2006;129(12):57-57. https://doi.org/10.1093/brain/awl313
  10. Westerlind H, Stawiarz L, Fink K, Hillert J, Manouchehrinia A. A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study. Mult Scler. 2016;22(8):1071-1079. https://doi.org/10.1177/1352458516643394
  11. Allison R, Millar J. Disseminated Sclerosis. BMJ. 1955;1(4926):1389-1390. https://doi.org/10.1136/bmj.1.4926.1389-d
  12. Schumacker GA. Critique of experimental trials of therapy in multiple sclerosis. Neurology. 1974;24(11):1010-1010. https://doi.org/10.1212/wnl.24.11.1010.
  13. McDonald WI, Halliday AM. Diagnosis and classification of multiple sclerosis. British Medical Bulletin. 1977;33(1):4-8. https://doi.org/10.1093/oxfordjournals.bmb.a071393
  14. Poser CM, Paty D.W, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Annals of Neurology. 1983;13(3):227-231. https://doi.org/10.1002/ana.410130302
  15. Lublin F, Reingold S. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology. 1996;46(4):907-911. https://doi.org/10.1212/wnl.46.4.907
  16. McDonald W, Compston A, Edan G, Goodkin D, Hartung H, Lublin F, Mcfarland H, Paty D, Polman C, Reingold S, Sandberg-Wollheim M, Sibley W, Thompson A, Van Den Noort S, Weinshenker B, Wolinsky J. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology. 2001;50(1):121-127. https://doi.org/10.1002/ana.1032
  17. Polman C, Wolinsky J, Reingold S. Multiple sclerosis diagnostic criteria: three years later. Multiple Sclerosis Journal. 2005;11(1):5-12. https://doi.org/10.1191/1352458505ms1135oa
  18. Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M, Fujihara K, havrdova E, Hutchinson M, Kappos L, Lublin F, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson A, Waubant E, Weinshenker B, Wolinsky J. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology. 2011;69(2):292-302. https://doi.org/10.1002/ana.22366
  19. Filippi M, Rocca M, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintore M, Frederiksen J, Gasperini C, Palace J, Reich D, Banwell B, Montalban X, Barkhof F. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. The Lancet Neurology. 2016;15(3):292-303. https://doi.org/10.1016/s1474-4422(15)00393-2
  20. Evdoshenko EP, Solodun IYu, Bashlakova EE, Holownia MA, Polyakova KI, Pokatilo AG, Khachanova NV, Davidovskaya MV, Skoromets AA. Budget impact analysis of teriflunomide (aubagio) proposed inclusion into the programme «7 high-cost nosologies» on the budgets of russian federation federal and regional public authorities in the field of healthcare to ensure treatment of multiple sclerosis patients. Pharmacoeconomics: theory and practice. 2016;4(1): 39-46. (In Russ.)
  21. Jacques F, Lublin F. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology. 2015;84(9):963-963. https://doi.org/10.1212/01.wnl.0000462309.76486.c5

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.